| Ms سوزان إل ليندكوست
| -- |
| Ms مارى سو كولمان
| -- |
| Mr كريستوفر دودس
| -- |
| Mr جافير تورول
| -- |
| Mr سي مارتن هاريس
| -- |
| Mr فرانك ميرغنثيلير
| -- |
| Ms ماري كرانستون
| شغلت السيدة ماري كرانستون منصب الرئيس والمدير التنفيذي لشركة بيلسبري من يناير 1999 حتى أبريل 2006 ، واستمرت في العمل كرئيسة لشركة بيلسبري حتى ديسمبر 2006. وقد مارست السيدة كرانستون دعاوى معقدة ، بما في ذلك دعاوى مكافحة الاحتكار والاتصالات السلكية واللاسلكية والأوراق المالية منذ عام 1975 ، وهي عضو في الكلية الأمريكية لمحامي المحاكمة. عضو مجلس إدارة شركة جراف تك الدولية المحدودة ، المعدل الدولي ، جونيبر نتوركس وفيزا ، إنك ، ماكيسون. |
| Mr جيمز بلامر
| -- |
| Mr جي توماس بريسبي
| -- |
| Mr بول اتش ستودارد
| -- |
| Mr جريج كريد
| -- |
| Mr إس جيمس نيلسون
| -- |
| Ms كونستانس جيه هورنر
| -- |
| Ms آن بيرزن
| -- |
| Mr جيمس ايه سكينر
| -- |
| Ms Christine King
| Ms Christine King is a director at Skyworks Solutions Inc since January 2014. Ms King has been a Director since October 20, 2008 and has been Chief Executive Officer and President of SMSC since October 20, 2008. Prior to that Ms King served as Chief Executive Officer and President of AMI Semiconductor, Inc. from September 2001 until March 2008. Ms King currently is a director of Idaho Power Company. She previously served as a director of AMI Semiconductor, Inc. from 2003 until its acquisition by ON Semiconductor Corporation in March 2008, as a director of ON Semiconductor Corporation from March 2008 until she left that position after joining SMSC in October 2008, as a director of Analog Devices, Inc. from 2003 to 2008 and as a director of Atheros Communications from April 2008 until its acquisition in May 2011. |
| Mr Bruce D. Broussard
| Mr Bruce D. Broussard is a director of Humana Inc since January 2013. Mr Broussard was elected President in December 2011. Prior to joining the Company, Mr Broussard was Chief Executive Officer of McKesson Specialty/US Oncology, Inc. US Oncology was purchased by McKesson in December 2010. At US Oncology, Mr Broussard served in a number of senior executive roles, including Chief Financial Officer, Chief Executive Officer and Chairman of the Board. |
| Mr William E. Mitchell
| Mr William E. Mitchell has served as a Class I Director since May 31, 2011 and shall hold office for an initial term expiring at the annual meeting of stockholders to be held in 2014. He is a director of Humana Inc since April 23, 2009. Mr Mitchell is also a member of the Nominating and Corporate Governance Committee. Mr Mitchell is the managing partner of Sequel Capital Management, LLC, a private equity firm that he founded. Mr Mitchell served as the chairman of the board of directors of Arrow Electronics, Inc from May 2006 until December 2009, and also served as President and Chief Executive Officer of Arrow Electronics, Inc. from February 2003 to May 1, 2009. Prior to that, Mr Mitchell was Executive Vice President of Solectron Global Services from 1999 to 2003 and was Chairman, President and Chief Executive Officer of Sequel, Inc. from 1995 to 1999 until its acquisition by Solectron. Mr Mitchell serves on the board of directors of Brown-Forman Corporation, Humana Inc. and Rogers Corporation. Mr Mitchell served on the board of directors of National Semiconductor until it was acquired by Texas Instruments in 2011. Mr Mitchell received his bachelor’s degree in engineering from Princeton University and his master’s degree in engineering from the University of Michigan. |
| Ms Marissa T. Peterson
| On July 26, 2011, the Board of Directors of the Company unanimously elected Marissa Peterson to serve as a Class II director of Oclaro Inc. She has been a Director at Humana Inc., since August 2008. Ms Peterson will serve as a member of the Compensation Committee and of the Audit Committee of the Board. Ms Peterson was formerly Executive Vice President, Worldwide Operations, Services & Customer Advocacy for Sun Microsystems Inc. in Santa Clara, California, until her retirement in 2005 after 17 years with the company. Ms Peterson currently serves on the board of directors for Ansell Limited, and the Lucile Packard Children's Hospital at Stanford and previously served on the board of directors of SUPERVALU INC. and the board of trustees of Kettering University. She also runs an executive coaching practice focused on helping grow and develop leaders in the high-technology space. |
| Mr David B. Nash
| Mr David B. Nash, M.D., M.B.A. was appointed to the Board of Endo Health Solutions Inc in March 2011 and is a member of Endo’s Compensation Committee. Also he is a director of Humana Inc since January 1, 2010. He is the founding dean of the Jefferson School of Population Health, located on the campus of Thomas Jefferson University in Philadelphia, Pennsylvania, having taken that position in 2008. Previously, Dr. Nash was the Chairman of the Department of Health Policy of the Jefferson Medical College from 2003 to 2008. Dr. Nash is internationally recognized for his work in outcomes management, medical staff development and quality-of-care improvement; his publications have appeared in more than 100 articles in major journals. Dr. Nash serves on the Board of Directors and is a member of the Audit Committee of Humana Inc., one of the nation’s largest publicly traded health and supplemental benefits companies. Dr. Nash also has served as a member of the Board of Trustees of Catholic Healthcare Partners in Cincinnati, Ohio. |
